Business
Board Changes
Frontier IP Group Plc announced that Matthew White, the Chief Commercialisation Officer, will be leaving the company to become the CEO of a Cambridge-based medical device company. Mr. White will remain in his current role and as an Executive Director until the end of his six-month notice period, which concludes on March 24, 2026. The Group has initiated discussions regarding a successor and plans to provide an update in due course. Disclaimer*

About this update from Frontier Ip Group Plc
[{"type":"text","content":"\n\nRNS\nAIM: FIPP\n25 September 2025\n \nFrontier IP Group Plc\n(\"Frontier IP\" or the \"Group\")\n \nAnnouncement of Board Change\n \nFrontier IP, a specialist in commercialising intellectual property, today announces that\nMatthew White (Chief Commercialisation Officer) has decided to leave the Group to pursue an opportunity as Chief Executive Officer of a Cambridge based early-stage medical devices company.\n \nIt is currently intended that Mr White will remain with the Company as Chief Commercialisation Officer and an Executive Director of the Company until the end of his six month notice period on 24 March 2026.\n \nThe Group is in discussions about a successor and a further update will be issued when appropriate.\n \nFrontier IP Chief Executive Officer Neil Crabb said: \"I am sorry Matt is leaving the Group. His departure is wholly amicable. In the seven years he has been our Chief Commercialisation Officer, he has played an invaluable role in the progress made by Frontier IP and our portfolio companies. I would like to wish him all the best in the exciting role he is to fulfil. I am sure he will be a great success.\"\n \nFrontier IP Chief Commercialisation Officer Matthew White said: \"It has been a privilege to be involved in the development of the Frontier IP portfolio over the last seven years. I look forward to the continued success of the portfolio and Frontier IP's growing engagement in the Cambridge deeptech ecosystem.\"\n \n \nENQUIRIES\n \n\n\n\n\nFrontier IP Group Plc\n\n\nT: 020 7332 2338\n\n\n\n\nNeil Crabb, Chief Executive\nAndrew Johnson, Communications & Investor Relations\nCompany website: www.frontierip.co.uk\n\n\[email protected]\nM: 07464 546 025\n\n\n\n\n \nAllenby Capital Limited (Nominated Adviser)\nNick Athanas / Daniel Dearden-Williams\n \nSinger Capital Markets (Broker)\nCharles Leigh-Pemberton / James Fischer\n\n\n \nT: 0203 328 5656\n \n \nT: 0207 496 3000\n\n\n\n\n\n\n\n\n\n \n \n \n\n\n\n\n \n \n \n\n","length":5848,"tagName":"div"}]